Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Myriad Genetics Inc (MYGN)  
$17.98 0.65 (3.49%) as of 4:30 Thu 4/25


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 94,542,000
Market Cap: 1.70(B)
Last Volume: 582,160 Avg Vol: 690,780
52 Week Range: $13.91 - $23.73
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  618
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Myriad Genetics is precision medicine company acting as an advisor to transform patient lives through molecular diagnostics. Co.'s molecular diagnostic tests are designed to analyze genes, their expression levels and corresponding proteins to assess an individual's risk for developing disease later in life, diagnose disease, determine a patient's likelihood of responding to a particular drug, or disease recurrence and assess a patient's risk of disease progression. Co. also provides biomarker discovery and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries utilizing its multiplexed immunoassay technology.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 30,000 38,638 109,679
Total Sell Value $0 $572,835 $771,595 $2,187,775
Total People Sold 0 1 2 3
Total Sell Transactions 0 1 2 9
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 1303
  Page 9 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Riggsbee Richard Bryan Chief Financial Officer   •       –      –    2021-09-21 4 A $0.00 $0 D/D 66,977 385,611     -
   Hart Jayne B. Chief People Officer   •       –      –    2021-09-21 4 A $0.00 $0 D/D 26,598 116,214     -
   Verratti Mark President, Myriad Neuroscience   •       –      –    2021-09-21 4 A $0.00 $0 D/D 56,571 212,619     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-09-21 4 A $0.00 $0 D/D 58,398 288,715     -
   Lambert Nicole See Remarks   •       –      –    2021-09-21 4 A $0.00 $0 D/D 65,870 192,921     -
   Hart Jayne B. Chief People Officer   •       –      –    2021-09-17 4 S $33.72 $2,274,279 D/D (67,446) 89,616 26%     
   Hart Jayne B. Chief People Officer   •       –      –    2021-09-17 4 OE $26.49 $2,039,730 D/D 77,000 92,582     -
   Lambert Nicole See Remarks   •       –      –    2021-08-27 4 AS $34.50 $32,603 D/D (945) 127,051 -29%     
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-25 4 D $34.81 $77,731 D/D (2,233) 230,317     -
   Verratti Mark President, Myriad Neuroscience   •       –      –    2021-08-25 4 D $34.81 $37,664 D/D (1,082) 156,048     -
   Riggsbee Richard Bryan Chief Financial Officer   •       –      –    2021-08-25 4 D $34.81 $106,449 D/D (3,058) 318,634     -
   Hart Jayne B. Chief People Officer   •       –      –    2021-08-25 4 D $34.81 $39,962 D/D (1,148) 80,062     -
   Lambert Nicole See Remarks   •       –      –    2021-08-25 4 D $34.81 $39,092 D/D (1,123) 127,996     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-24 4 AS $35.57 $1,067,100 D/D (30,000) 232,550 -24%     
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-24 4 OE $27.07 $812,100 D/D 30,000 262,550     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-23 4 AS $35.07 $1,758,500 D/D (50,000) 232,550 -20%     
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-23 4 OE $27.07 $1,353,500 D/D 50,000 272,550     -
   Diaz Paul J President and CEO   •       •      –    2021-08-13 4 D $32.79 $1,928,708 D/D (58,820) 400,049     -
   Riggsbee Richard Bryan Chief Financial Officer   •       –      –    2021-08-10 4 GD $0.00 $0 D/D 3,250 321,692     -
   Phanstiel S. Louise Director   –       •      –    2021-08-05 4 OE $21.29 $1,400,400 D/D 60,000 91,646     -
   Phanstiel S. Louise Director   –       •      –    2021-08-05 4 S $35.04 $1,677,741 D/D (47,881) 61,646 27%     
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-05 4 AS $35.57 $1,004,008 D/D (28,225) 232,550 -27%     
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-05 4 OE $27.07 $764,051 D/D 28,225 260,775     -
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-04 4 AS $35.24 $1,766,027 D/D (50,000) 232,550 -27%     
   Lanchbury Jerry S Chief Scientific Officer   •       –      –    2021-08-04 4 OE $27.07 $1,353,500 D/D 50,000 244,325     -
  1303 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us